Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline

Biotech IPOs that are getting out remain hot — but will that continue into the fall? On the latest BioCentury This Week podcast, BioCentury’s analysts discuss the market for fresh biotech paper on NASDAQ, including the $770 million debut by  Parabilis, the largest IPO in the sector’s history.The analysts also discuss the Biosecure Act and U.S. policy toward China; the cachexia pipeline; and BioCentury’s updated Innovation Distillery.View full story: https://www.biocentury.com/article/659773 #BiotechIPO #NASDAQ #BiosecureAct #Cachexia #ChinaBiotech 00:36 - Innovation Distillery03:56 - Biotech IPOs10:13 - Biosecure Act, WuXi AppTec16:03 - Cachexia Pipeline22:03 - Ouster for RFK Jr.?To submit a question to BioCentury’s editors, email the BioCentury This Week team at [email protected] us by sending a text